Company / Net Debt per Share
BioXcel Therapeutics, Inc. Net Debt per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
$26.17
FY2025
5-year range
-$3.60 / $38.83
FY2022-FY2025
Trend
-32.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $1.26 to $26.17 over the past 2 years.
Based on SEC 10-K filings.
26.17 in FY2025.
Increased from $1.26 to $26.17 over the past 2 years.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, net debt per share decreased 32.6% year-over-year.
Company context
Key Data Points
- Altman Z-Score -17.49 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $26.17 | -32.6% |
| FY2024 | $38.83 | +2989.6% |
| FY2023 | $1.26 | +134.9% |
| FY2022 | -$3.60 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026